PTC Therapeutics
PTCT
$25.53
Share price
-0.58%
Change (1 day)
-46.61%
Change (1 year)
Categories
Operating Margin for PTC Therapeutics (PTCT)
Operating Margin as of September 2023 (TTM): -84.20%
According to PTC Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -84.20%. At the end of 2022 the company had an Operating Margin of -71.07%.
Operating Margin history for PTC Therapeutics from 2012 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -71.07% | -11.46% |
| 2021 | -80.27% | -11.81% |
| 2020 | -91.02% | 44.93% |
| 2019 | -62.80% | 72.57% |
| 2018 | -36.39% | 10.04% |
| 2017 | -33.07% | -79.29% |
| 2016 | -159.67% | -64.87% |
| 2015 | -454.58% | 5% |
| 2014 | -432.93% | 198.74% |
| 2013 | -144.92% | 55.57% |
| 2012 | -93.15% | -401.43% |
| 2011 | 30.90% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 17.27% | -120.51% | 🇨🇭 Switzerland |
 Vertex Pharmaceuticals VRTX | 47.39% | -156.28% | 🇺🇸 USA |
 Xencor XNCR | -141.63% | 68.21% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | -88.19% | 4.74% | 🇺🇸 USA |
 Fate Therapeutics
FATE | -191.80% | 127.79% | 🇺🇸 USA |
 Avidity Biosciences RNA | -1,886.32% | 2,140.29% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.